Store
In Vitro Diagnostics Business Outlook, 2025 (6 updates)
Publication Date: June 24, 2025
Tags: Coagulation, COVID-19, Genetic Diseases, Hematology, Histology and Cytology, Immunoassay, In Vitro Diagnostics (IVD), Infectious Diseases, Molecular Diagnostics, Oncology and Cancer, Point-of-Care (POC) Testing
Pages: Varies (average 30 pages)
SKU: 25-014KA
The in vitro diagnostics (IVD) sector stands as a cornerstone of modern healthcare, empowering clinicians with the tools to detect diseases, monitor health conditions, and guide precise treatment decisions.
As healthcare evolves, the IVD market is poised for transformative growth. With the rising prevalence of chronic conditions such as diabetes and cardiovascular diseases, as well as ongoing threats from infectious diseases like COVID-19 and emerging variants, the demand for innovative diagnostic solutions has never been greater.
In Vitro Diagnostics Business Outlook is a bimonthly publication, delivering six issues annually, each dedicated to a different segment of the IVD industry. It provides exclusive insights and data, including:
- Market Data and Forecasts: Detailed growth rates, market size, and market share to identify new opportunities.
- Comprehensive Market View: Coverage of test categories and company profiles.
- M&A Activities: Updates on mergers, acquisitions, partnerships, and collaborations.
- Industry & Region Watch: Tailored strategies based on regional and industry-specific trends.
- News Analysis: In-depth reporting on significant news and events, including exclusive information not readily available elsewhere.
Table: Global Lab-Based Immunoassay Market, by Segment, 2024-2029 ($ million)
| 2024 | % Mkt | 2029 | % Mkt | CAGR | |
| Allergy | $XX Million | $XX Million | $XX Million | XX% | XX% |
| Anemia | $XX Million | $XX Million | $XX Million | XX% | XX% |
| Autoimmune | $XX Million | $XX Million | $XX Million | XX% | XX% |
| Blood Bank Screening | $XX Million | $XX Million | $XX Million | XX% | XX% |
| Cardiac Markers | $XX Million | $XX Million | $XX Million | XX% | XX% |
| COVID-19 | $XX Million | $XX Million | $XX Million | XX% | XX% |
| Diabetes/HbA1c | $XX Million | $XX Million | $XX Million | XX% | XX% |
| Fertility | $XX Million | $XX Million | $XX Million | XX% | XX% |
| HAIs/Sepsis | $XX Million | $XX Million | $XX Million | XX% | XX% |
| Hepatitis | $XX Million | $XX Million | $XX Million | XX% | XX% |
| HIV | $XX Million | $XX Million | $XX Million | XX% | XX% |
| Lyme disease | $XX Million | $XX Million | $XX Million | XX% | XX% |
| Mycology | $XX Million | $XX Million | $XX Million | XX% | XX% |
| Parasitology | $XX Million | $XX Million | $XX Million | XX% | XX% |
| Proteins | $XX Million | $XX Million | $XX Million | XX% | XX% |
| Respiratory (excl. COVID) | $XX Million | $XX Million | $XX Million | XX% | XX% |
| STD | $XX Million | $XX Million | $XX Million | XX% | XX% |
| Therapeutic Drugs | $XX Million | $XX Million | $XX Million | XX% | XX% |
| Thyroid | $XX Million | $XX Million | $XX Million | XX% | XX% |
| ToRCH | $XX Million | $XX Million | $XX Million | XX% | XX% |
| Tox/Drug of Abuse | $XX Million | $XX Million | $XX Million | XX% | XX% |
| Tumor Markers | $XX Million | $XX Million | $XX Million | XX% | XX% |
| Vitamin D | $XX Million | $XX Million | $XX Million | XX% | XX% |
| Other Infectious Disease | $XX Million | $XX Million | $XX Million | XX% | XX% |
| Others Non-Infectious Disease | $XX Million | $XX Million | $XX Million | XX% | XX% |
Source: Kalorama Information
For further details and to purchase directly, please contact us.
Table of Contents
Volume 4, Issue 1 – Focus on Cardiac Biomarkers
Market Analysis: Cardiac Biomarker Testing
Overview of Cardiac Biomarkers
Market Outlook
- Figure: Cardiac Marker Testing Market by End User, 2024-2029 ($ million) (Lab-based, POC-based)
- Table: Cardiac Marker Diagnostic Sales by End User, 2024-2029 ($ million) (Lab-based, POC-based)
- Figure: Cardiac Marker Testing Market by End User and Total Value Over Time, 2019-2029 ($ million) (Lab-based, PoC-based)
- Figure: Cardiac Marker Testing Market, by Marker, 2024 (% Share) (Troponin, BNP, CK-MB, Myoglobin, Other)
Regional Market
- Table: Cardiac Marker Test Sales Distribution by Global Region, 2024 (%) (Asia Pacific, Europe, North America, RoW)
Company Briefs
Abbott Diagnostics
Beckman Coulter
Siemens
Vendor Market Share
- Figure: Market Share of Leading Vendors in the Cardiac Marker Segment, by Company, 2024 (%) (Abbott, Danaher, QuidelOrtho, Roche, Siemens, Others)
Executive News Briefing
Briefs
Senseera Closes $7.1 Million in Funding Round
Geneoscopy Closes Series C Funding
Oxford Cancer Analytics Raises $11 Million in Series A Funding
MiRXES Nabs $40 Million in Financing
Tethis Nabs €15 Million Funding
Financial Highlights: Becton Dickinson, Natera
Becton Dickinson Reports 4% Revenue Growth in Fiscal 2024
- Table: Becton Dickinson Financial Review, by Business Segment, FY 2022-FY 2024 ($ million) (BD Medical, BD Life Sciences, BD Interventional)
- Figure: Becton Dickinson Business Division Performance, by Business Segment, FY 2022-FY 2024 ($ million) (BD Medical, BD Life Sciences, BD Interventional)
- Figure: BD Life Sciences Division, Segment Mix, FY 2020 vs. FY 2024 (%) (Integrated Diagnostic Solutions, Biosciences)
- Figure: Becton Dickinson U.S./International Revenue Distribution, FY 2022-FY 2024 ($ million)
- Figure: Becton Dickinson Revenue Distribution, by Region, FY 2024 (%) (EMEA, Greater Asia, United States, Other)
Natera Continues Overall Growth Trend with Preliminary 2024 Results, Expecting a 56% Increase over 2023
- Figure: Natera Financial Overview by Quarter, Q1 2023-Q4 2024* ($ million)
Diagnostic Market Mergers, Acquisitions, and Partnership Deals
Partnerships and Collaborations
Mergers and Acquisitions
- Table: Recent Diagnostic Market Mergers, Acquisitions, and Partnership Deals, Dec. 2023-Jan. 2025
Industry Watch
Industry Watch COVID-19/Flu Update
Region Watch
Mexico
- Figure: Mexico GDP, GDP (PPP), and Health Spending, 1990-2020, estimated 2025 ($ billion)
- Figure: Mexico IVD Market Sales Trends, by Broad IVD Segment, 2016-2024 ($ million) (Clinical Chemistry, Hematology, and Coagulation; Histology; Immunoassays; Microbiology; POC; Others)
Broad-based Company Announcements
Announcements
Roche Secures CE Marking for Mass Spec System
QIAGEN Receives FDA Clearance for Five-Target Syndromic Panel
Revvity Secures FDA Clearance for Free Testosterone Test
Spear Bio Secures FDA Breakthrough Device Designation
Roche Announces Clearance of First ISH Test B-cell Lymphoma
Roche Receives Additional FDA Clearance
Volume 4, Issue 2 – Focus on Infectious Disease Testing
Market Analysis: Infectious Disease Testing
Overview of Infectious Disease Testing
Market Outlook
- Table 1: Global Infectious Disease Testing Market Revenue, by Segment, 2024-2029 ($ million) [Lab-based Immunoassays, Lab-based Molecular, Point-of-Care Tests]
- Figure 1: Global Infectious Disease Testing Market, by Segment, 2019-2029 ($ million) [Lab-based Immunoassays, Lab-based Molecular, Point-of-Care Tests]
- Figure 2: Global Infectious Disease Testing Market, Change in Market Performance by Segment, 2023-2024 [Blood Bank Screening, COVID-19, HAIs/Sepsis, Hepatitis, HIV, Respiratory (excl. COVID), Others]
- Figure 3: Global Infectious Disease Testing Market, by Analyte Target, Distribution of Sales, 2024 [Blood Bank Screening, COVID-19, HAIs/Sepsis, Hepatitis, HIV, Respiratory (excl. COVID), Others]
Regional Market
- Table 2: Infectious Disease Testing, Distribution by Global Region, 2024 [North America, Europe, Asia Pacific, RoW]
Company Briefs
Roche
Abbott
Danaher
Other Participants
Executive News Briefing
Briefings
Dxcover Limited Raises New Capital
Cubit Diagnostics Awarded NIH Funding
CARB-X Funds AstraDx’s Neonatal Sepsis Rapid Test
Freenome Raises Additional $254 Million
Renovaro Secures $15 Million in New Capital
Ataraxis AI Secures $20.4 Million in Funding
MSInsight Nabs €1.6 Million Seed Funding
C2N Diagnostics Receives $10 Million Investment
Financial Highlights: Guardant Health, Roche
Guardant Reports Strong Demand – Increasing Revenues +31% Over Previous Year
- Figure 4: Guardant Health Test Volume, by Segment and Total, Quarterly Q1 2023 through Q4 2024 [Biopharmaceutical Customers, Clinical Customers]
- Table 3: Guardant Health, by Group Business Revenue, FY 2023 vs FY 2024 ($ million) [Clinical Precision Oncology Testing, Development Services and Other]
- Figure 5: Guardant Health, by Group Business, FY 2023 vs FY 2024 ($ million) [Clinical Precision Oncology Testing, Development Services and Other]
- Figure 6: Guardant Health Revenue Performance, by Geographic Region, FY 2023 vs FY 2024 ($ million) [United States, International]
Roche Diagnostic Sales Grow 4% CER in 2024 – Supported by Demand for Immunodiagnostics, Pathology, and Molecular Solutions
- Table 4: Roche, by Group Business, 2024 (CHF MN) [Diagnostic Division, Pharmaceutical Division]
- Figure 7: Roche Diagnostics, 2024 Product Sales Breakdown, 2024 (CHF MN) [Core Lab, Molecular, Pathology Lab, Point-of-Care]
- Figure 8: Roche Diagnostic, Segment Distribution, 2024 (%) [Core Lab, Molecular, Pathology Lab, Point-of-Care]
- Table 5: Roche Diagnostics Division Sales, by Region, 2024 (CHF MN)
Diagnostic Market Mergers, Acquisitions, and Partnership Deals
Mergers and Acquisitions
- Table 6: Recent Diagnostic Market Mergers, Acquisitions, and Partnership Deals, Dec. 2024-March 2025
Partnerships and Collaborations
Industry Watch
Industry Watch COVID-19/Flu Update
Region Watch
Brazil
- Figure 9: Brazil Short-Term GDP Growth and Inflation Change, 2022-2024, 2025-2026 Projected (%)
- Figure 10: Brazil General Government Gross Debt as a Percent of GDP, 2000-2020 and 2025 projected (%)
- Figure 11: Brazil IVD Market Distribution of Sales, by IVD Segment, 2024 (%)
Broad-based Company Announcements
Announcements
AliveDx Nabs CE Mark for Expanded Autoimmune Menu
Beckman Coulter Received FDA Breakthrough Device Designation
Beckton Dickinson to Spin Off Bioscience and Diagnostic Business
GRAIL Provides Galleri Multi-Cancer Early Detection Test Through Quest
Molecular Instruments RNA-ISH Enables Breakthrough LDT
Roche Snags FDA Clearance for Preeclampsia Test
CytoChip Receives FDA Clearance and CLIA Waiver
Cicero Diagnostics Unveiled Endometriosis Detection LDT
bioMérieux Secures FDA Clearance for BIOFIRE FILMARRAY GI Panel
Beckman Coulter Gains Clearance for its DxC 500i
Volume 4, Issue 3 – Focus on Blood Grouping/Typing Testing
About Kalorama Information
Market Analysis: Blood Grouping/Typing Testing
Overview of Blood Grouping/Typing Testing
Molecular Methods in Blood Typing
Discovery of a New Blood Group System
Market Outlook: Blood Grouping and Typing
Overview of Blood Grouping and Typing
Regional Market
- Figure: Blood Grouping/Typing Market, Estimated Revenues, by Global Region, 2019-2029 [Asia Pacific, Europe, North America, Rest of World]
Company Briefs
Bio-Rad
Grifols
QuidelOrtho
- Figure: Global Blood Grouping/Typing Market Share, by Vendor, 2024 (%) [Bio-Rad, Grifols, QuidelOrtho, Others]
Werfen/Immucor
AliveRx/Quotient
Executive News Briefing
Briefs
Craif Raises $22 Million in Series C Funding
Deepull Closes Series C Financing Round
Upfront Diagnostics Raises $4.3 million in Funding Round
Cizzle Biotechnology Raises £150,000 in Additional Funding
Hedera Dx Lands €15 Million in Funding
32 Biosciences Secures $6 Million in Funding
Financial Highlights: bioMérieux & Trinity Biotech
bioMérieux Reports Full-Year 2024 Sales of €3,980 Million, Representing 10.3% Organic Growth and Exceeding Expectations
- Figure: Trinity Biotech Sales, by Business Segment, FY 2023 and FY 2024 ($ thousands) [Clinical Laboratory, Point-of-Care]
Diagnostic Market Mergers, Acquisitions, and Partnership Deals
Partnerships and Collaborations
Recent Mergers and Acquisitions
- Table: Recent Diagnostic Market Mergers, Acquisitions, and Partnership Deals, December 2024-June 2025
Industry Watch
Industry Watch COVID-19/Flu Update
Region Watch
China
- Figure: China Total Health Expenditures, $ Billion and Total Population, 2010-2023
- Figure: China IVD Market Distribution of Sales, by IVD Segment, 2024 (%)
Broad-based Company Announcements
Company Announcements
Guardant Health Launches New Hereditary Cancer Test
EDX Medical Launches Test for Early Testicular Cancer Detection
Lumipulse G pTau 217 β-Amyloid 1-42 Plasma Ratio Receives FDA Clearance
Boditech and SphingoTec Launch AFIAS Sphingotest penKid Assay
Roche Plans Investment of $550 Million for Indianapolis Diagnostic Site
Roche Receives FDA Breakthrough Device Designation
DiaSorin Captures FDA Clearance for Multiplex Molecular Panel
Nordic Bioscience Launches nordicEndotrophin Assay
genedrive Certification of Rapid CYP2C19 ID Kit
Predicta Biosciences Launches GenoPredicta Marrow and GenoPredicta Blood
Baebies Received FDA Breakthrough Device Designation
New Day Diagnostics Launches ColoHealth
Randox Received FDA Go-Ahead for ConcizuTrace ELISA
LifeLabs Introduces Three Blood-Based Alzheimer’s Disease Tests
Related products
In Vitro Diagnostic (IVD) Procedure Volumes, 2023-2028
October 22, 2023
Gain invaluable insights into the global IVD market with Kalorama Information’s comprehensive report In Vitro Diagnostic (IVD) Procedure Volumes (Chemistry, Immunoassays, Hematology, Microbiology, Histology, Point of Care), 2023-2028. This analysis provides essential data on the number of IVD procedures, offering a gold standard for new entrants and existing marketers in the diagnostic products industry.
…
Price range: $6,000.00 through $9,000.00
Clinical Laboratory Services Market, 8th Edition
May 18, 2023
Laboratories are the workhorse of diagnostic services for the IVD market. These laboratories play a vital role in providing analysis of a wide range of disorders and diseases including pathology, immunology, cholesterol testing, allergy testing, urinalysis, genetic testing and many more. Kalorama Information’s Clinical Laboratory Services Market, 8th Edition is your comprehensive resource for insights…
Price range: $4,000.00 through $6,000.00
The World Market for Veterinary Diagnostics, 7th Edition
January 22, 2024
Unlock the potential of the veterinary diagnostics market with Kalorama Information’s comprehensive report, The World Market for Veterinary Diagnostics, 7th Edition, which dives deep into the world of animal healthcare diagnostics. From disease identification to monitoring, veterinarians rely on a variety of tests for accurate diagnoses and effective treatment plans. Our report provides a detailed…
Price range: $5,000.00 through $7,875.00
